NovaBridge Biosciences (NBP)
1.02
-0.05
(-4.67%)
USD |
NASDAQ |
Nov 03, 14:22
NovaBridge Biosciences Market Cap : 118.32M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 124.12M |
| October 30, 2026 | 138.62M |
| October 29, 2026 | 140.36M |
| October 28, 2026 | 146.16M |
| October 27, 2026 | 145.58M |
| October 26, 2026 | 140.94M |
| October 23, 2026 | 158.92M |
| October 22, 2026 | 154.28M |
| October 21, 2026 | 158.92M |
| October 20, 2026 | 165.30M |
| October 19, 2026 | 150.80M |
| October 16, 2026 | 146.16M |
| October 15, 2026 | 149.64M |
| October 14, 2026 | 148.48M |
| October 13, 2026 | 149.64M |
| October 12, 2026 | 153.12M |
| October 09, 2026 | 161.82M |
| October 08, 2026 | 158.92M |
| October 07, 2026 | 158.92M |
| October 06, 2026 | 162.40M |
| October 05, 2026 | 157.76M |
| October 02, 2026 | 157.18M |
| October 01, 2026 | 155.44M |
| September 30, 2026 | 158.34M |
| September 29, 2026 | 158.92M |
| Date | Value |
|---|---|
| September 28, 2026 | 157.76M |
| September 25, 2026 | 160.08M |
| September 24, 2026 | 168.20M |
| September 23, 2026 | 177.48M |
| September 22, 2026 | 184.44M |
| September 21, 2026 | 186.76M |
| September 18, 2026 | 185.60M |
| September 17, 2026 | 189.08M |
| September 16, 2026 | 182.12M |
| September 15, 2026 | 184.44M |
| September 14, 2026 | 186.76M |
| September 11, 2026 | 184.44M |
| September 10, 2026 | 196.04M |
| September 09, 2026 | 197.20M |
| September 08, 2026 | 206.48M |
| September 04, 2026 | 208.80M |
| September 03, 2026 | 208.80M |
| September 02, 2026 | 207.64M |
| September 01, 2026 | 200.68M |
| August 31, 2026 | 211.12M |
| August 28, 2026 | 213.44M |
| August 27, 2026 | 219.24M |
| August 26, 2026 | 216.92M |
| August 25, 2026 | 223.88M |
| August 24, 2026 | 219.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xencor, Inc. | 2.300B |
| Arrivent BioPharma, Inc. | 646.52M |
| ACADIA Pharmaceuticals, Inc. | 3.568B |
| Alnylam Pharmaceuticals, Inc. | 21.32B |
| Anika Therapeutics, Inc. | 256.82M |
Market Cap Related Metrics
| Price | 1.02 |